RNAZ - Transcode Therapeutics regains compliance with Nasdaq listing rules January, 31 2024 04:14 PM TransCode Therapeutics Inc. 2024-01-31 16:14:21 ET More on TransCode Therapeutics TransCode Therapeutics announces retirement of CEO TransCode Therapeutics announces $1.2M registered direct offering of common stock For further details see: Transcode Therapeutics regains compliance with Nasdaq listing rules